Find information on Type 2 Diabetes Mellitus with Neuropathy diagnosis, including ICD-10 codes E11.4 and G63.2, clinical documentation requirements, diabetic neuropathy symptoms, treatment options, and healthcare guidelines. Learn about peripheral neuropathy, autonomic neuropathy, coding best practices for diabetes with neurological manifestations, and resources for medical professionals. Explore diabetes management, nerve damage assessment, and the impact of hyperglycemia on the nervous system.
Also known as
Type 2 diabetes with polyneuropathy
Type 2 diabetes with neuropathy, unspecified or involving multiple nerves.
Type 2 diabetes with amyotrophy
Type 2 diabetes with nerve damage causing muscle weakness and wasting.
Type 2 diabetes with mononeuropathy
Type 2 diabetes affecting a single nerve, such as carpal tunnel syndrome.
Type 2 diabetes with other neuropathy
Type 2 diabetes with nerve damage, not classified elsewhere.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diabetes Type 2?
Yes
Is there diabetic neuropathy?
No
Review documentation and code the correct diabetes type. Neuropathy codes still apply if present.
When to use each related code
| Description |
|---|
| Type 2 diabetes with neuropathy |
| Type 2 diabetes with nephropathy |
| Type 2 diabetes with retinopathy |
Coding neuropathy without specifying the type (e.g., peripheral, autonomic) leads to lower reimbursement and data inaccuracy.
Lack of proper documentation to support the neuropathy diagnosis can trigger audits and claim denials. CDI can clarify this.
Incorrect sequencing of diabetes and neuropathy codes can impact HCC risk adjustment and payment accuracy. Review ICD-10 guidelines.
Patient presents with symptoms consistent with type 2 diabetes mellitus with associated peripheral neuropathy. Presenting complaints include hyperglycemia, polyuria, polydipsia, and paresthesia in the lower extremities described as tingling and numbness. The patient reports a family history of diabetes. Physical examination reveals diminished sensation to light touch and vibration in the feet bilaterally. Laboratory results show elevated HbA1c of 8.5%, fasting blood glucose of 160 mgdL, and impaired glucose tolerance test results. Diagnosis of type 2 diabetes mellitus with peripheral neuropathy is confirmed. The patient's current medications include metformin, but dosage adjustments and additional interventions are warranted. Treatment plan includes lifestyle modifications such as dietary changes focusing on carbohydrate control and increased physical activity, intensification of pharmacologic therapy with consideration for insulin therapy, and referral to a podiatrist for ongoing foot care management to prevent diabetic foot ulcers. Patient education provided on diabetes management, neuropathy symptoms, and the importance of regular blood glucose monitoring. Follow-up scheduled in four weeks to assess glycemic control, evaluate neuropathy progression, and adjust treatment as needed. ICD-10 codes E11.4 and G63.2 assigned.